Exact Sciences Corporation (NASDAQ: EXAS) stock enjoyed a major increase of 26.8% on 8/1/24. The shares closed at $57.91. Moreover, exceptionally high trading volume at 352% of normal accompanied the advance. The stock has been […]
Stock Rating Downgrade The Value Trend Rating for Distribution Solutions Group Inc (NASDAQ: DSGR) weakened of late from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included […]
On 8/1/24, CareDx Inc (NASDAQ: CDNA) stock enjoyed a major increase of 18.0%, closing at $23.58. Moreover, this advance was accompanied by exceptionally high trading volume at 562% of normal. The stock has risen 28.0% […]
Camtek Ltd (NASDAQ: CAMT) has reported E.P.S. of $0.62 for its second fiscal quarter (ending June 30) versus $0.42 for the same period a year ago. For the latest four quarters through June 30, E.P.S. […]
Blueprint Medicines Corp (NASDAQ: BPMC) has reported E.P.S. of $-0.80 for its second fiscal quarter (ending June 30) versus $-2.19 for the same period a year ago. For the latest four quarters through June 30, […]
Stock Rating Downgrade The Value Trend Rating for American Woodmark Corp (NASDAQ: AMWD) weakened recently from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Willis Lease Finance Corp (NASDAQ: WLFC) has reported E.P.S. of $6.34 for its second fiscal quarter (ending June 30) versus $2.04 for the same period a year ago. For the latest four quarters through June […]
Stock Rating Downgrade In the last week the Value Trend Rating for The Joint Corp (NASDAQ: JYNT) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action The Joint Corp […]
On 8/1/24, Revance Therapeutics Inc (NASDAQ: RVNC) stock suffered a major decline of -10.8%, closing at $3.37. This decline was accompanied by normal trading volume. Relative to the market the stock has been extremely weak […]
Pilgrim’s Pride Corp (NASDAQ: PPC) has recently enjoyed meaningful positive changes in fundamentals: the consensus estimate for December, 2025 increased significantly, the consensus estimate for December, 2024 increased significantly, and significant quarterly earnings acceleration occurred. […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research